Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis

Authors:

Abstract
Background & Aims: Systemic inflammation in advanced cirrhosis represents a spectrum ranging from subclinical pathological bacterial translocation and immune activation to overt bacterial infection and sepsis. We hypothesized that systemic inflammation in cirrhosis is accompanied by a failure of ADAMTS13 to control the prothrombotic function of von Willebrand factor (VWF), which is increased in portal hypertension and hepatic fibrosis.Methods: Patients with Child A cirrhosis (n = 25), Child B/C cirrhosis without clinical features of systemic inflammation (n = 31), and Child B/C cirrhosis with overt bacterial infections or systemic inflammatory response syndrome (n = 24) were analysed for ADAMTS13 and associated parameters and were followed to determine transplant‐free survival.Results: Plasma concentration and activity of ADAMTS13 were decreased in patients with systemic inflammation. Furthermore, ADAMTS13 inversely correlated with the extent of bacterial translocation and the severity of acute‐phase reaction. As a function of reduced ADAMTS13 activity and increased VWF antigen, plasma from patients with superimposed inflammation strongly aggregated the platelet receptor glycoprotein Ib in presence of ristocetin. VWF:RCo correlated with higher concentrations of leucocytes and lipopolysaccharide‐binding protein, organ dysfunction, augmented turnover of cross‐linked intravascular fibrin, and the occurrence of acute kidney injury during follow‐up. VWF:RCo of 390% or more predicted transplant‐free survival in univariate analysis [HR = 8.24 (3.30–20.54)] and after adjustment for MELD [HR = 3.58 (1.30–9.88)]. However, adverse outcome was not associated with the accumulation of high‐molecular weight VWF multimers.Conclusions: Systemic inflammation complicating advanced cirrhosis is accompanied by reduced activity of ADAMTS13 promoting a prothrombotic function of VWF, which can be employed to predict clinical outcome.
Funding Information
  • Federal Ministry of Education and Research (FKZ: 01 E0 1002)
  • German Research Foundation (BR 4182/1-1)
  • Jena Center for interdisciplinary research

This publication has 44 references indexed in Scilit: